This week, The New York Times published a fascinating article about something that only a few years ago was considered essentially impossible: successfully targeting KRAS, the mutation that drives the majority of pancreatic cancer cases, as well as many forms of lung and colorectal cancer.
The article describes how researchers managed to develop a new drug, daraxonrasib, which in studies nearly doubled survival compared with traditional treatment in patients with advanced pancreatic cancer.
This is not yet a finished medicine. And we should be careful not to overstate early results. At the same time, it is hard to underestimate the significance of a field long regarded as biologically "unsolvable" now actually beginning to deliver clinical results.
At Executive Health, this is especially close to our hearts. We have had pancreatic cancer in our own family. It is a disease that is often detected late, progresses quickly, and where medical progress has historically come painfully slowly.
That is precisely why this kind of research feels so important.
Perhaps the most interesting part of the article is not just the drug itself, but what it symbolises. For decades, researchers described KRAS as "undruggable", meaning impossible to attack with medication. A bit as if everyone had accepted that the problem simply could not be solved. And then, someone solved it anyway.
Medical history is full of such moments:
- Cholesterol went from "natural ageing" to treatable.
- HIV went from a death sentence to a chronic disease.
- Immunotherapy went from experiment to Nobel Prize.
Now we may be standing at the beginning of something similar in some of the most aggressive forms of cancer.
For us, this also reinforces another conviction: the importance of early detection and of following medical developments closely. Many of the great breakthroughs in medicine feel "sudden" when they reach the headlines, but are actually built on decades of persistent research, improved diagnostics and technological progress.
That is why we believe so strongly in combining:
- advanced screening,
- data-driven prevention,
- longitudinal follow-up,
- and respect for what the evidence actually says, not what the hype cycle says.
It is easy to become cynical about medical news today. But sometimes something comes along that actually deserves the word breakthrough.
And perhaps this is the beginning of such a moment.
Source: The New York Times article "How an 'Impossible' Idea Led to a Pancreatic Cancer Breakthrough"
